1 / 25

An Unexpected Post-op Complication

An Unexpected Post-op Complication Andy Fox Principal Pharmacist, Southampton University Hospitals NHS Trust. An Unexpected Post-op Complication. Andy Fox Principal Pharmacist – Risk Tamsin Griffiths SpR Paediatrics. Introduction. Case Presentation Root cause analysis Learning. Day 1.

stellal
Télécharger la présentation

An Unexpected Post-op Complication

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. An Unexpected Post-op Complication Andy Fox Principal Pharmacist, Southampton University Hospitals NHS Trust

  2. An Unexpected Post-op Complication Andy Fox Principal Pharmacist – Risk Tamsin Griffiths SpR Paediatrics

  3. Introduction • Case Presentation • Root cause analysis • Learning

  4. Day 1 • 4yr old boy, 16.6kg • Admitted 6/2/09 am • Vomiting, abo pain? Bladder spasm • Catheterised, bladder scan - Oxybutinin • In CRF - renal dysplasia and Reflux • eGFR 20ml/min/1.73m2

  5. The case progresses (Day 1) • 2230hrs On-going pain & spasms • Written up for Baclofen 10mg tds by surgical reg • Dose at 23.00 and again at 06:00

  6. Day 2 • 1200hrs – lethargic - Baclofen stopped • Gradual deterioration • 16.30 Fluctuating Conscious level • Imp • ?sepsis, ?intracranial pathology ?drug reaction/ toxicity • Transferred to PICU & intubated • CT scan – Normal • Baclofen Toxicity

  7. Further progress • Labile BP • HF considered to reduce drug levels but appeared to be improving • Ventilated for 46hrs • Subsequent good recovery, normal neurological function

  8. Baclofen Kinetics • GABA derivative • Onset of effect in 30-40 mins • Peak levels in 2hrs • Route of excretion : Renal 70-90% • Half life 3-4h,

  9. Baclofen levels (microg/L) • 7/2/8 (D2) pm 610 • 8/2/8 1045 320 • 1645 208 • 2300 140 • Therapeutic range = 80-400microg/l • Ventilated despite levels • Half-life = 10hrs

  10. Paediatric overdose • Baclofen party! • 14 symptomatic, 9 intubated • Of 8 pts - coma (7), hypothermia (6) bradycardia (5) arrythmias (PVC) (3), convulsions (2) • Persistent symptoms despite levels • All discharged within 5 days

  11. Baclofen toxicity • Multiple adult reports in literature- • Prolonged recovery phase noted • Elimination rate from nerve tissue much slower • Toxicity unmasking renal failure

  12. Root Cause Analysis (Compiled by Dr McIntosh, PICU)

  13. Root Cause Analysis: Good Points • Frequent reviews • Appropriate management plan • Senior review

  14. Problems • Baclofen dose is wrong • Delay in escalation of care • Initial differential of sepsis/dehydration not in keeping with bradycardia.

  15. RCA: Baclofen dose too high • Why? • Because that is the maintenance BNF dose for age for children with normal renal function • Why not give the renal failure dose? • Not identified as needing to • Why not? • Renal function (estimated GFR) was given on flow sheet & in previous letters • Not in latest electronic letter

  16. Baclofen dose too high • Urology team may not look at flow sheets • May not look for GFR • No suggestion that the BNF dose for renal impairment was misread • No suggestion that GFR was looked at and thought satisfactory

  17. Root Cause • Failure to identify patient in renal failure who needs dose adjusting

  18. Suggestions • CRF patients sticker on • notes • drug charts • eGFR in letters • Induction • On-going education

  19. Suggestions • 5. Poster at nurses station • 6. BNFC is vague in the renal dose alteration. Communication has been made with them. • 7. Audit

  20. References Holly E. Perry , Robert O. Wright , Michael W. Shannon , and Alan D. Woolf Baclofen Overdose: Drug Experimentation in a Group of AdolescentsPediatrics, Jun 1998; 101: 1045 - 1048. D. J. Lipscomb and T. J. MeredithBaclofen overdose.Postgrad. Med. J., Feb 1980; 56: 108 - 109. 

  21. Acknowledgments • Tamsin Griffiths Spr • Mark Tomlin- Consultant pharmacist SUHT • Shuman Haq – Consultant Paediatric Nephroloist

  22. Learning!

  23. Any Questions?

More Related